QUCY

Conviction 57HealthcareScan · Mon, Jul 20, 2026

Inverted hammer

QUCY$1.17-4.88%

ResistanceSupportVol 14

Vol MA14 1.05M

Apr 20May 6May 26Jun 11Jul 1Jul 20

Quantum Cyber N.V.PHARMACEUTICAL PREPARATIONSquantum-cyber.ai ↗

Price1.17

Change-4.88%

Gap-4.47%

Rel volume0.02×

Avg volume4.59M

Avg $ vol7.24M

SMA 201.40

SMA 501.88

SMA 200—

Price vs 50-37.91%

Price vs 200—

MA stack—

50/200 cross—

Supertrenddown · 1.68

RSI (14)36

MACD hist-0.01

MACD cross—

Stoch %K / %D9 / 12

ADX (14)13

+DI / −DI23 / 24

RSI divergence—

MACD divergenceBullish

ATR %+17.23%

ADR %10.07%

52w high3.56

52w low0.3228

From 52w high-67.13%

Above 52w low+262.45%

New 52w highNo

SqueezeOn · 4d

Bollinger width39.55%

%B0.08

Donchian pos6.25%

Donchian high1.92

Donchian low1.12

AVWAP (52w high)2.83

vs AVWAP high-58.65%

AVWAP (52w low)2.09

vs AVWAP low-43.90%

OBV trendUp

Chaikin MF (20)-0.39

Today vs 20d0.02×

Avg vol (14d)1.05M

Avg vol (20d)4.59M

Avg $ vol (20d)7.24M

Market cap17.15M

RS 3m (vs SPY)+137.92%

RS 6m (vs SPY)—

RS line new highNo

Trend template—

Technical rank5.7

1 week-7.14%

1 month-38.42%

3 months+140.25%

6 months—

1 year—

YTD+54.27%

P/E-1.06

P/B3.74

P/S31.94

P/FCF-1.56

EPS-2.70

Div yield—

ROE-353.23%

ROA-210.04%

Debt/Eq0.21

Current2.11

EV/EBITDA-0.86

Gross margin72.58%

Net margin—

Rev growth-39.92%

EPS growth24.95%

Price target—

Target upside—

Analyst rating—

Institutional1.37%

Ent. value13.41M

Revenue—

Net income-5.08M

Gross profit—

Free cash flow-10.98M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out22.77M

Employees13

ListedFri, Nov 5, 2021

Free float11.37M

Float %90.8%

Short interest3.37M

Days to cover0.4d

Short volume34.9%

Squeeze score42 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeC

Conviction57 / 100

Pattern quality—

Tech rank5.7 / 100

Group rank23 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmInverted hammer

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in QUCY

All disclosures →

No recent disclosed trades by Congress in QUCY. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in QUCY · 5 buys

Insider	Side	Shares	Value	Traded	Filed
O'Rourke Peter Director · Stock Option (Right to Buy) · 2026-07-06	Grant	112.86K	—	2026-07-06	2026-07-07
Ben-Tzvi Avraham Director · Ordinary Shares · 2026-05-08	Grant	137.14K	$0	2026-05-08	2026-05-26
NATAN DAVID Director · Ordinary Shares · 2026-05-08	Grant	137.14K	$0	2026-05-08	2026-05-21
Lazar David E. Chief Executive Officer · Series E Preferred Shares · 2026-04-22	Grant	1M	$1.5M	2026-04-22	2026-04-28
Lazar David E. Chief Executive Officer · Series D Preferred Shares · 2026-04-22	Grant	1M	$1.5M	2026-04-22	2026-04-28
Lazar David E. Chief Executive Officer · Ordinary Shares · 2026-04-22	Other	—	—	2026-04-22	2026-04-28

SEC filings

EDGAR filings in QUCY · 9 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.